NEL Psoriasis pathway

NameDownload link
Psoriasis HCD pathway (NEL) V1.4_ March 2024CLICK TO DOWNLOAD
High Cost Drug, Biologic, Anti-TNF, IL23, IL17, TYK2 Inhibitor,
Adalimumab, Certolizumab, Etanercept, Infliximab, Apremilast,
Dimethyl Fumarate, Bimekizumab, Brodalumab, Ixekizumab,
Secukinumab, Ustekinumab, Guselkumab, Risankizumab,
Tidrakizumab, Deucravacitini

This website is for healthcare professions only.

It is not for public use.

Feedback
Feedback
How would you rate your experience?
Do you have any additional comment?
Next
Enter your email if you'd like us to contact you regarding with your feedback.
Back
Submit
Thank you for submitting your feedback!